BACKGROUND: The American Heart Association (AHA), in conjunction with the National
Institutes of Health, annually reports the most up-to-date statistics related to heart disease …

Abstract Purpose of Review To summarize selected late-breaking science on cardiovascular
(CV) disease prevention presented at the 2024 Scientific Session of the American College of …

Background Coronary artery calcium (CAC) is a strong predictor of cardiovascular events
across all racial and ethnic groups. CAC can be quantified on nonelectrocardiography …

Background Cardiovascular disease is the leading cause of mortality in Germany.
Cardiovascular risk can be mitigated with long-term lipid-lowering therapies (LLTs) that …

Background: The role of statin therapy in the development of kidney disease in patients with
type 2 diabetes mellitus (DM) remains uncertain. We aimed to determine the relationships …

Importance Many patients with coronary artery disease (CAD) do not achieve the guideline-
directed goals for low-density lipoprotein cholesterol (LDL-C) levels. Objective To estimate …

Abstract Purpose of Review Summarize selected late-breaking science on cardiovascular
(CV) disease prevention presented at the 2022 scientific session of the American Heart …

Aims Patients with cancer are at increased cardiovascular (CV) risk. We aimed to compare
the recommended and observed statin use among individuals with and without cancer …

Objectives Trends in prevalence and treatments of atherosclerotic cardiovascular disease
(ASCVD) remains to be documented, with frequent update of relevant guidelines. We aimed …

Background Atherosclerosis-related cardiovascular diseases (coronary heart diseases,
ischemic stroke, and peripheral vascular diseases) account for the majority of deaths in …